These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18372254)

  • 1. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate.
    Nyboe Andersen A; Balen A; Platteau P; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2008 Jun; 23(6):1424-30. PubMed ID: 18372254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2361-5. PubMed ID: 9661609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
    J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.
    López E; Gunby J; Daya S; Parrilla JJ; Abad L; Balasch J
    Reprod Biomed Online; 2004 Oct; 9(4):382-90. PubMed ID: 15511336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
    Fertil Steril; 2002 Jan; 77(1):91-7. PubMed ID: 11779596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.
    Imani B; Eijkemans MJ; Faessen GH; Bouchard P; Giudice LC; Fauser BC
    Fertil Steril; 2002 Jan; 77(1):83-90. PubMed ID: 11779595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone.
    Ozkaya O; Kaya H; Sezik M; Akyürek C; Ozbaşar D
    Int J Fertil Womens Med; 2004; 49(2):83-7. PubMed ID: 15188834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; te Velde ER; Habbema JD; Fauser BC
    J Clin Endocrinol Metab; 1999 May; 84(5):1617-22. PubMed ID: 10323389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
    Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Eijkemans MJ; Habbema JD; Fauser BC
    Semin Reprod Med; 2003 Feb; 21(1):39-47. PubMed ID: 12806558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility.
    van Santbrink EJ; Eijkemans MJ; Macklon NS; Fauser BC
    Eur J Endocrinol; 2002 Aug; 147(2):223-6. PubMed ID: 12153744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WITHDRAWN: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 1996 Apr; (1):CD000087. PubMed ID: 17636586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol.
    Budinetz TH; Benadiva CA; Griffin DW; Engmann LL; Nulsen JC; DiLuigi AJ
    Fertil Steril; 2015 Mar; 103(3):675-9. PubMed ID: 25577463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.
    Balen AH; Platteau P; Andersen AN; Devroey P; Sørensen P; Helmgaard L; Arce JC
    BJOG; 2006 Oct; 113(10):1195-202. PubMed ID: 16903840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?
    Burgers JA; Fong SL; Louwers YV; Valkenburg O; de Jong FH; Fauser BC; Laven JS
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E485-9. PubMed ID: 20843954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.